The other, forgotten genome: Mitochondrial DNA and mental disorders

Molecular Psychiatry

Volumn 6, Issue 6, 2001, Pages 625-633

  Kato, T ^a  

^a RIKEN BRAIN SCIENCE INSTITUTE   (Japan)

Author keywords

Bipolar disorder; Electron transport chain; Mitochondria; Molecular genetics; Postmortem brain; Schizophrenia

Indexed keywords

CYTOCHROME C OXIDASE; MESSENGER RNA; MITOCHONDRIAL DNA;

AFFECTIVE NEUROSIS; AGING; ALZHEIMER DISEASE; COMORBIDITY; DEGENERATIVE DISEASE; ENCEPHALOMYOPATHY; GENE DELETION; GENETIC POLYMORPHISM; HISTOPATHOLOGY; HUMAN; INHERITANCE; MANIC DEPRESSIVE PSYCHOSIS; MENTAL DISEASE; NEURORADIOLOGY; PARKINSON DISEASE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RESPIRATORY CHAIN; REVIEW; SCHIZOPHRENIA;

BIPOLAR DISORDER; DNA, MITOCHONDRIAL; ELECTRON TRANSPORT; GENOME, HUMAN; HUMANS; POLYMORPHISM, GENETIC; SCHIZOPHRENIA;

EID: 0034751559     PISSN: 13594184     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.mp.4000926     Document Type: Review

References (124)

1. Sequence and organization of the human mitochondrial genome
2. Deletions of muscle mitochondrial DNA in patients with mitochondrial myopathies
3. (Leu)(UUR) gene associated with the MELAS subgroup of mitochondrial encephalomyopathies
4. Mitochondria and free radicals
5. 2+ signaling
6. Abnormal calcium homeostasis and mitochondrial polarization in a human encephalomyopathy
7. A calcium signaling defect in the pathogenesis of a mitochondrial DNA inherited oxidative phosphorylation deficiency
8. Normal variants of human mitochondrial DNA and translation products: The building of a reference data base
9. Mitochondrial genetics
10. Human cells lacking mtDNA: Repopulation with exogenous mitochondria by complementation
11. Functional integrity of mitochondrial genomes in human platelets and autopsied brain tissues from elderly patients with Alzheimer's disease
12. A subtype of diabetes mellitus associated with a mutation of mitochondrial DNA
13. MITOMAP: A human mitochondrial genome database - 1998 Update
14. Fragile mitochondrial DNA: The missing link in the apoptotic neuronal cell death in Parkinson's disease
15. The 'common deletion' is not increased in Parkinsonian substantia nigra as shown by competitive polymerase chain reaction
16. Mitochondrial involvement in Alzheimer's disease
17. Gene expression of ND4, a subunit of complex I of oxidative phosphorylation in mitochondria, is decreased in temporal cortex of brains of Alzheimer's disease patients
18. Detection of point mutations in codon 331 of mitochondrial NADH dehydrogenase subunit 2 in Alzheimer's brains
19. Mitochondrial DNA variants observed in Alzheimer disease and Parkinson disease patients
20. A mitochondrial DNA clone is associated with increased risk for Alzheimer disease
21. Association of the mitochondrial tRNA(A4336G) mutation with Alzheimer's and Parkinson's diseases
22. Is a point mutation in the mitochondrial ND2 gene associated with Alzheimer's disease
23. No association of mutations at nucleotide 5460 of mitochondrial NADH dehydrogenase with Alzheimer's disease
24. Investigations on the point mutations at nt 5460 of the mtDNA in different neurodegenerative and neuromuscular diseases
25. No association found between Alzheimer's disease and a mitochondrial tRNA glutamine gene variant
26. mtDNA polymorphisms in Japanese sporadic Alzheimer's disease
27. Mitochondrial DNA mutations in Alzheimer's disease
28. Mutations in mitochondrial cytochrome c oxidase genes segregate with late-onset Alzheimer disease
29. Apparent mtDNA heteroplasmy in Alzheimer's disease patients and in normals due to PCR amplification of nucleus-embedded mtDNA pseudogenes
30. Ancient mtDNA sequences in the human nuclear genome: A potential source of errors in identifying pathogenic mutations
31. Evidence that two reports of mtDNA cytochrome c oxidase 'mutations' in Alzheimer's disease are based on nDNA pseudogenes of recent evolutionary origin
32. Increased apoptosis of Huntington disease lymphoblasts associated with repeat length-dependent mitochondrial depolarization
33. Mitochondria in sporadic amyotrophic lateral sclerosis
34. Characterization of cybrid cell lines containing mtDNA from Huntington's disease patients
35. Calcium homeostasis and reactive oxygen species production in cells transformed by mitochondria from individuals with sporadic Alzheimer's disease
36. Altered calcium homeostasis in cells transformed by mitochondria from individuals with Parkinson's disease
37. Mitochondrial DNA mutations as an important contributor to aging and degenerative diseases
38. Mitochondrial DNA deletions in human brain: Regional variability and increase with advanced age
39. Aging-dependent large accumulation of point mutations in the human mtDNA control region for replication
40. Mitochondrial genotype associated with longevity
41. Mitochondrial DNA inherited variants are associated with successful aging and longevity in humans
42. In vivo neurochemistry of the brain in schizophrenia as revealed by magnetic resonance spectroscopy
43. Morbidity risk of schizophrenia to parents and siblings of schizophrenic patients
44. Sex differences in the familial transmission of schizophrenia
45. Schizophrenia gender and familial risk
46. Risk factors for schizophrenia
47. Mitochondrial encephalomyopathies: Biochemical studies in two cases revealing defects in the respiratory chain
48. Mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes: A distinctive clinical syndrome
49. A case report of MELAAS; on various psychiatric symptoms as acute exogenous reaction type
50. A case of mitochondrial encephalomyopathy (MELAS) with the psychotic features
51. Familial cases of mitochondria cytopathy
52. Mitochondrial encephalopathy (MELAS) with mental disorder. CT, MRI, and SPECT findings
53. A case of mitochondrial encephalopathy with schizophrenic psychosis, dementia and neuroleptic malignant syndrome
54. Psychiatric symptoms in MELAS; a case report
55. Psychosis and progressing dementia: Presenting features of a mitochondriopathy
56. Mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS) syndrome: An autopsy report
57. Diabetes mellitus associated with mitochondrial myopathy and schizophrenia: A possible link between diabetes mellitus and schizophrenia
58. Psychiatric symptoms in a patient with diabetes mellitus associated with point mutation in mitochondria DNA
59. Absence of association between a mitochondrial DNA mutation at nucleotide position 3243 and schizophrenia in Japanese
60. Mitochondrial involvement in schizophrenia and other functional psychoses
61. Superoxide, neuroleptics and the ubiquinone and cytochrome b5 reductases in brain and lymphocytes from normals and schizophrenic patients
62. A study of altered gene expression in frontal cortex from schizophrenic patients using differential screening
63. Decreased cytochrome-c oxidase activity and lack of age-related accumulation of mitochondrial DNA deletions in the brains of schizophrenics
64. Neuroleptic-induced mitochondrial enzyme alterations in the rat brain
65. Normalization of cytochrome-c oxidase activity in the rat brain by neuroleptics after chronic treatment with PCP or methamphetamine
66. Mitochondrial function is differentially altered in the basal ganglia of chronic schizophrenics
67. Putamen mitochondrial energy metabolism is highly correlated to emotional and intellectual impairment in schizophrenics
68. Mitochondrial pathology in human schizophrenic striatum: A postmortem ultrastructural study
69. Synaptic contacts in schizophrenia: Studies using immunocytochemical identification of dopaminergic neurons
70. Mitochondrial sequence variants in patients with schizophrenia
71. Mitochondrial DNA variants in schizophrenia: Association studies
72. T2 hyperintensities in bipolar disorder; magnetic resonance imaging comparison and literature meta-analysis
73. Mitochondrial disorders: Analysis of their clinical and imaging characteristics
74. 7Li magnetic resonance spectroscopy
75. 31P-MRS in bipolar disorder: A confirmation in drug-free patients and correlation with white matter hyperintensity
76. Reduction of brain phosphocreatine in bipolar II disorder detected by phosphorus-31 magnetic resonance spectroscopy
77. 31P magnetic resonance spectroscopy in the frontal lobe of major depressed patients
78. Lower levels of nucleoside triphosphate in the basal ganglia of depressed subjects: A phosphorous-31 magnetic resonance spectroscopy study
79. 31P-MR spectroscopy
80. 31P-MR spectroscopy in patients with MELAS
81. Brain activation in normal subjects and in patients affected by mitochondrial disease without clinical central nervous system involvement: A phosphorus magnetic resonance spectroscopy study
82. Two genetic factors in manic-depressive disease
83. Patterns of maternal transmission in bipolar affective disorder
84. Maternal inheritance and chromosome 18 allele sharing in unilineal bipolar pedigrees
85. Clinical evidence for genomic imprinting in bipolar I disorder
86. Parent-of-origin effect in the transmission of bipolar disorder
87. Evaluating the parent-of-origin effect in bipolar affective disorder. Is a more penetrant subtype transmitted paternally?
88. Evidence for linkage of bipolar disorder to chromosome 18 with a parent-of-origin effect
89. Patterns of parental transmission and familial aggregation models in bipolar affective disorder
90. A new manifestation of Leber's disease and a new explanation for the agency responsible for its unusual pattern of inheritance
91. A case of mitochondrial encephalopathy misdiagnosed as Alzheimer's disease, with various kinds of neurological and psychiatric symptoms
92. Manic-depressive psychosis in a patient with mitochondrial myopathy - A case report
93. Multiple deletions of mitochondrial DNA
94. Multiple deletions of mitochondrial DNA in several tissues of a patient with severe retarded depression and familial progressive external ophthalmoplegia
95. Mitochondrial myopathy associated with sudden death in young adults and a novel mutation in the mitochondrial DNA leucine transfer RNA(UUR) gene
96. MELAS point mutation with unusual clinical presentation
97. Deletion of leukocyte mitochondrial DNA in bipolar disorder
98. Psychiatric disturbance in mitochondrial diabetes due to 3243 mitochondrial tRNA mutation
99. Leu(UUR) mutation
100. Mental disorders in diabetic patients with mitochondrial transfer RNALeu(UUR) mutation at position 3243
101. Quantitative analysis of leukocyte mitochondrial DNA deletion in affective disorders
102. A nuclear defect in the 4p16 region predisposes to multiple mitochondrial DNA deletions in families with Wolfram syndrome
103. Predisposition of Wolfram syndrome heterozygotes to psychiatric illness
104. A gene encoding a transmembrane protein is mutated in patients with diabetes mellitus and optic atrophy (Wolfram syndrome)
105. Diabetes insipidus, diabetes mellitus, optic atrophy and deafness (DIDMOAD) caused by mutations in a novel gene (wolframin) coding for a predicted transmembrane protein
106. A locus for bipolar affective disorder on chromosome 4p
107. A rare coding variant within the wolframin gene in bipolar and unipolar affective disorder cases
108. Mutational analysis of the wolfram syndrome gene in two families with chromosome 4p-linked bipolar affective disorder
109. Bipolar disorder and variation at a common polymorphism (A1832G) within exon 8 of the wolfram gene
110. WFS1 gene mutation search in depressive patients: Detection of five missense polymorphisms but no association with depression or bipolar affective disorder
111. WFS1 (Wolfram syndrome 1) gene product: Predominant subcellular localization to endoplasmic reticulum in cultured cells and neuronal expression in rat brain
112. Homozygosity mapping identifies an additional locus for Wolfram syndrome on chromosome 4q
113. The possible association between affective disorder and partially deleted mitochondrial DNA
114. Increased levels of a mitochondrial DNA deletion in the brain of patients with bipolar disorder
115. Mitochondrial genetic analyses suggest selection against maternal lineages in bipolar affective disorder
116. Mitochondrial DNA polymorphisms in bipolar disorder
117. Association of bipolar disorder with the 5178 polymorphism in mitochondrial DNA
118. Mitochondrial DNA sequence diversity in bipolar affective disorder
119. Mitochondrial dysfunction in bipolar disorder
120. Identifying a series of candidate genes for mania and psychosis: A convergent functional genomics approach
121. Quantitation and origin of the mitochondrial membrane potential in human cells lacking mitochondrial DNA
122. The occurrence of depressive symptoms in the preclinical phase of AD: A population-based study
123. Dementia in affective disorder: A case-register study